Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies

Fang Cheng(Union Hospital), Fang Zeng(Lumtec (Taiwan))
Frontiers in Oncology
February 6, 2023
Cited by 33


Related Papers